CD8A and non-small cell lung carcinoma: Accordingly, Ruffini et al. observed that CD8+ cells were associated with prolonged survival in 1290 stage I-IIIA NSCLC patients, but that an independent prognostic impact was associated with squamous cell carcinomas only [30].